Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amisulpride, quantity: 400 mg - tablet, film coated - excipient ingredients: macrogol 6000; methylcellulose; purified talc; magnesium stearate; sodium starch glycollate type a; microcrystalline cellulose; basic butylated methacrylate copolymer; titanium dioxide; lactose monohydrate - amisulpride is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.

Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - amisulpride - oral tablet - 100mg

Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - amisulpride - oral tablet - 200mg

Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - amisulpride - oral tablet - 50mg

Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - amisulpride - oral tablet - 200mg

Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - amisulpride - oral tablet - 200mg

Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - amisulpride - oral tablet - 200mg

Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

dowelhurst ltd - amisulpride - oral tablet - 400mg

Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - amisulpride - oral tablet - 400mg

Ingilterra - Ingliż - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - amisulpride - oral tablet - 100mg